Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glioblastoma | 7 | 2013 | 1797 | 0.290 |
Why?
|
Telomere | 3 | 2015 | 505 | 0.260 |
Why?
|
PTEN Phosphohydrolase | 6 | 2015 | 986 | 0.230 |
Why?
|
Brain Neoplasms | 7 | 2015 | 4849 | 0.220 |
Why?
|
Cell Differentiation | 6 | 2015 | 4078 | 0.210 |
Why?
|
Telomerase | 3 | 2012 | 525 | 0.180 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2014 | 1331 | 0.160 |
Why?
|
RNA-Binding Proteins | 3 | 2013 | 984 | 0.150 |
Why?
|
Glioma | 3 | 2015 | 1963 | 0.140 |
Why?
|
Mitochondria | 3 | 2012 | 1282 | 0.140 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2014 | 1439 | 0.130 |
Why?
|
Hematopoiesis | 2 | 2015 | 560 | 0.120 |
Why?
|
ErbB Receptors | 2 | 2015 | 2295 | 0.120 |
Why?
|
Neoplastic Stem Cells | 3 | 2013 | 1443 | 0.110 |
Why?
|
Genes, Essential | 1 | 2012 | 48 | 0.110 |
Why?
|
Mice | 19 | 2015 | 34495 | 0.110 |
Why?
|
RNA Stability | 1 | 2012 | 125 | 0.100 |
Why?
|
Telomere Homeostasis | 1 | 2012 | 73 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2014 | 1724 | 0.100 |
Why?
|
Pancreatic Neoplasms | 3 | 2014 | 5061 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 4 | 2012 | 1823 | 0.100 |
Why?
|
Smad4 Protein | 1 | 2011 | 196 | 0.090 |
Why?
|
Adenocarcinoma | 3 | 2014 | 7789 | 0.090 |
Why?
|
Animals | 20 | 2015 | 59536 | 0.090 |
Why?
|
Sequence Deletion | 1 | 2012 | 875 | 0.090 |
Why?
|
Transcription Factors | 6 | 2014 | 5270 | 0.080 |
Why?
|
Stem Cells | 2 | 2010 | 1213 | 0.080 |
Why?
|
Cell Cycle | 2 | 2014 | 2084 | 0.080 |
Why?
|
Phosphoproteins | 1 | 2014 | 1152 | 0.080 |
Why?
|
Lymphoma, T-Cell | 2 | 2012 | 361 | 0.080 |
Why?
|
Wnt Proteins | 1 | 2010 | 397 | 0.080 |
Why?
|
Hematopoietic Stem Cells | 2 | 2011 | 1242 | 0.080 |
Why?
|
Genes, Tumor Suppressor | 4 | 2012 | 1064 | 0.080 |
Why?
|
Genes, myc | 1 | 2009 | 358 | 0.070 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2007 | 65 | 0.070 |
Why?
|
Disease Models, Animal | 4 | 2014 | 7222 | 0.070 |
Why?
|
Carcinogenesis | 1 | 2013 | 1026 | 0.070 |
Why?
|
Proteins | 3 | 2010 | 1963 | 0.070 |
Why?
|
DNA-Binding Proteins | 4 | 2014 | 4821 | 0.070 |
Why?
|
Chromosomal Instability | 1 | 2007 | 233 | 0.070 |
Why?
|
Forkhead Transcription Factors | 1 | 2010 | 778 | 0.070 |
Why?
|
Conserved Sequence | 1 | 2007 | 469 | 0.070 |
Why?
|
Molecular Targeted Therapy | 2 | 2015 | 2330 | 0.070 |
Why?
|
Cell Proliferation | 7 | 2012 | 7226 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2012 | 3552 | 0.070 |
Why?
|
Homeostasis | 1 | 2010 | 950 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2010 | 992 | 0.060 |
Why?
|
Cell Line | 1 | 2012 | 5114 | 0.060 |
Why?
|
Genes, p53 | 1 | 2009 | 1090 | 0.060 |
Why?
|
Mice, Transgenic | 4 | 2015 | 4143 | 0.060 |
Why?
|
Prostatic Neoplasms | 2 | 2012 | 5767 | 0.060 |
Why?
|
NF-kappa B | 1 | 2011 | 1549 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2012 | 8873 | 0.050 |
Why?
|
Signal Transduction | 4 | 2012 | 11965 | 0.050 |
Why?
|
Cytokines | 1 | 2011 | 2809 | 0.050 |
Why?
|
Myelodysplastic Syndromes | 1 | 2015 | 2979 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2015 | 6942 | 0.050 |
Why?
|
MicroRNAs | 2 | 2012 | 2947 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2015 | 5178 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2015 | 476 | 0.050 |
Why?
|
Neoplasm Metastasis | 1 | 2011 | 5112 | 0.050 |
Why?
|
Ameloblasts | 1 | 1999 | 7 | 0.050 |
Why?
|
Incisor | 1 | 1999 | 9 | 0.050 |
Why?
|
Cell Line, Tumor | 5 | 2014 | 14551 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2007 | 1960 | 0.040 |
Why?
|
Glycosyltransferases | 1 | 1999 | 34 | 0.040 |
Why?
|
Disease Progression | 1 | 2011 | 6682 | 0.040 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 2 | 2010 | 265 | 0.040 |
Why?
|
Gene Knockdown Techniques | 2 | 2012 | 1077 | 0.040 |
Why?
|
Xenopus Proteins | 1 | 1999 | 185 | 0.040 |
Why?
|
Neoplasm Invasiveness | 3 | 2012 | 3981 | 0.040 |
Why?
|
Multiprotein Complexes | 2 | 2010 | 395 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2010 | 2326 | 0.040 |
Why?
|
Fibroblast Growth Factors | 1 | 1999 | 257 | 0.040 |
Why?
|
Neurons | 1 | 2008 | 2287 | 0.040 |
Why?
|
Humans | 18 | 2015 | 261506 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2010 | 3022 | 0.040 |
Why?
|
Reactive Oxygen Species | 2 | 2012 | 987 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2013 | 5159 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2015 | 5395 | 0.030 |
Why?
|
Serine-Arginine Splicing Factors | 1 | 2015 | 88 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2010 | 810 | 0.030 |
Why?
|
Ribonucleoproteins | 1 | 2015 | 123 | 0.030 |
Why?
|
E2F Transcription Factors | 1 | 2014 | 132 | 0.030 |
Why?
|
Doxycycline | 1 | 2015 | 178 | 0.030 |
Why?
|
Cell Cycle Proteins | 2 | 2014 | 2045 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2010 | 1546 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2012 | 3154 | 0.030 |
Why?
|
Erlotinib Hydrochloride | 1 | 2015 | 388 | 0.030 |
Why?
|
Haploinsufficiency | 1 | 2015 | 294 | 0.030 |
Why?
|
RNA Splicing | 1 | 2015 | 370 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2013 | 151 | 0.030 |
Why?
|
Phosphonoacetic Acid | 1 | 2012 | 18 | 0.030 |
Why?
|
RNA Splicing Factors | 1 | 2013 | 153 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2013 | 5710 | 0.030 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2012 | 87 | 0.030 |
Why?
|
Genes, cdc | 1 | 2012 | 81 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 2012 | 241 | 0.030 |
Why?
|
Neural Stem Cells | 1 | 2013 | 181 | 0.030 |
Why?
|
Quinolines | 1 | 2015 | 383 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 1082 | 0.020 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2012 | 327 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2012 | 266 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2015 | 803 | 0.020 |
Why?
|
Penetrance | 1 | 2011 | 126 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2010 | 2359 | 0.020 |
Why?
|
Osteopontin | 1 | 2011 | 148 | 0.020 |
Why?
|
Gluconeogenesis | 1 | 2011 | 121 | 0.020 |
Why?
|
Pancytopenia | 1 | 2010 | 120 | 0.020 |
Why?
|
Homozygote | 1 | 2012 | 717 | 0.020 |
Why?
|
DNA Replication | 1 | 2014 | 744 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2013 | 7548 | 0.020 |
Why?
|
Quinazolines | 1 | 2015 | 923 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2010 | 189 | 0.020 |
Why?
|
ras Proteins | 1 | 2014 | 770 | 0.020 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2012 | 430 | 0.020 |
Why?
|
Hydroxamic Acids | 1 | 2012 | 442 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2011 | 406 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2011 | 268 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 2 | 2014 | 2488 | 0.020 |
Why?
|
Imidazoles | 1 | 2015 | 999 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2011 | 311 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2012 | 1519 | 0.020 |
Why?
|
Mice, SCID | 1 | 2013 | 1869 | 0.020 |
Why?
|
RNA Interference | 1 | 2013 | 1408 | 0.020 |
Why?
|
Genomic Instability | 1 | 2012 | 519 | 0.020 |
Why?
|
Membrane Proteins | 1 | 1999 | 2819 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 571 | 0.020 |
Why?
|
Cyclin D1 | 1 | 2011 | 576 | 0.020 |
Why?
|
Pyridines | 1 | 2015 | 1244 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2010 | 413 | 0.020 |
Why?
|
Models, Neurological | 1 | 2009 | 225 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 634 | 0.020 |
Why?
|
Species Specificity | 1 | 2009 | 777 | 0.020 |
Why?
|
Lysosomes | 1 | 2010 | 347 | 0.020 |
Why?
|
Synteny | 1 | 2007 | 87 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2010 | 1008 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 2508 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2011 | 993 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 622 | 0.020 |
Why?
|
Phosphorylation | 1 | 2015 | 4804 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2010 | 1070 | 0.020 |
Why?
|
Apoptosis | 2 | 2010 | 7591 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 2216 | 0.020 |
Why?
|
Pyrazoles | 1 | 2015 | 1471 | 0.020 |
Why?
|
Mice, Nude | 1 | 2013 | 4307 | 0.020 |
Why?
|
RNA | 1 | 2011 | 1013 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2013 | 1491 | 0.020 |
Why?
|
Gene Deletion | 1 | 2010 | 1442 | 0.020 |
Why?
|
Prostate | 1 | 2011 | 1088 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2011 | 1130 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2012 | 1516 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2012 | 1547 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 2011 | 610 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 1879 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2013 | 5637 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2011 | 1678 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2012 | 2086 | 0.020 |
Why?
|
Myocardium | 1 | 2011 | 1313 | 0.020 |
Why?
|
Cell Survival | 1 | 2010 | 3045 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 1265 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2015 | 3343 | 0.010 |
Why?
|
Doxorubicin | 1 | 2011 | 3005 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2008 | 4053 | 0.010 |
Why?
|
Genome | 1 | 2007 | 672 | 0.010 |
Why?
|
Aging | 1 | 2011 | 1582 | 0.010 |
Why?
|
Models, Biological | 1 | 2011 | 3254 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2011 | 4844 | 0.010 |
Why?
|
Genomics | 1 | 2012 | 2738 | 0.010 |
Why?
|
Liver | 1 | 2011 | 2961 | 0.010 |
Why?
|
Fibroblast Growth Factor 3 | 1 | 1999 | 22 | 0.010 |
Why?
|
Mutation | 2 | 2011 | 15179 | 0.010 |
Why?
|
Fibroblast Growth Factor 10 | 1 | 1999 | 26 | 0.010 |
Why?
|
Culture Techniques | 1 | 1999 | 132 | 0.010 |
Why?
|
Serrate-Jagged Proteins | 1 | 1999 | 85 | 0.010 |
Why?
|
Jagged-1 Protein | 1 | 1999 | 101 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2012 | 2576 | 0.010 |
Why?
|
Phenotype | 1 | 2010 | 6295 | 0.010 |
Why?
|
Survival Analysis | 1 | 2010 | 9180 | 0.010 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 1999 | 153 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1999 | 521 | 0.010 |
Why?
|
Mesoderm | 1 | 1999 | 404 | 0.010 |
Why?
|
Male | 3 | 2012 | 123000 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 1999 | 545 | 0.010 |
Why?
|
Regeneration | 1 | 1999 | 279 | 0.010 |
Why?
|
Female | 3 | 2013 | 141928 | 0.010 |
Why?
|
Cell Lineage | 1 | 1999 | 668 | 0.010 |
Why?
|
Receptors, Notch | 1 | 1999 | 383 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 1999 | 650 | 0.010 |
Why?
|
Cell Division | 1 | 1999 | 2489 | 0.010 |
Why?
|
Biomarkers, Tumor | 1 | 2012 | 10331 | 0.010 |
Why?
|
Prognosis | 1 | 2011 | 21713 | 0.010 |
Why?
|
Epithelial Cells | 1 | 1999 | 1818 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 14289 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1999 | 6150 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2011 | 11538 | 0.000 |
Why?
|
Neoplasms | 1 | 2012 | 15193 | 0.000 |
Why?
|